Author:
Hale Jaime E.,Parad Richard B.,Dorkin Henry L.,Gerstle Robert,Lapey Allen,O’Sullivan Brian P.,Spencer Terry,Yee William,Comeau Anne Marie
Subject
Genetics (clinical),Genetics
Reference12 articles.
1. Atkinson K, Zuckerman B, Sharfstein J, Levin D, Blatt RJR, Koh H (2001) A public health response to emerging technology: expansion of the Massachusetts newborn screening program. Public Health Rep 116:122–131
2. Borowitz D, Parad RB, Sharp JS et al (2009) Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. J Pediatr 155(6, Suppl 1):S71–S116
3. Code of Massachusetts Regulations (2008): 105 CMR 270.000 sections 270.001-011. Blood screening of newborns for treatable diseases and disorders
4. Comeau AM, Parad RB, Dorkin HL et al (2004) Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics 113:1573–1581
5. Comeau AM, Accurso FJ, White TB et al (2007) Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report. Pediatrics 119:2e495–e518
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献